methoxyhydroxyphenylglycol has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanada, H; Yoneda, M | 1 |
| Dale, JK; Demitrack, MA; Gold, PW; Kling, MA; Krahn, DD; Straus, SE | 1 |
| Brickman, A; Goodnick, PJ; Klimas, NG; Sandoval, R | 1 |
1 review(s) available for methoxyhydroxyphenylglycol and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
[3-methoxy-4-hydroxyphenylglycol (MHPG)].
Topics: Alzheimer Disease; Anorexia Nervosa; Biomarkers; Bipolar Disorder; Chromatography, High Pressure Liquid; Depression; Fatigue Syndrome, Chronic; Gas Chromatography-Mass Spectrometry; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Reference Values; Schizophrenia; Specimen Handling | 2005 |
2 other study(ies) available for methoxyhydroxyphenylglycol and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: preliminary findings.
Topics: Adult; Anxiety Disorders; Blood-Brain Barrier; Cohort Studies; Depressive Disorder; Fatigue Syndrome, Chronic; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Somatoform Disorders | 1992 |
Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome.
Topics: Adult; Bupropion; Depressive Disorder; Fatigue Syndrome, Chronic; Female; Fluoxetine; Follow-Up Studies; Homovanillic Acid; Humans; Immunity, Cellular; Male; Methoxyhydroxyphenylglycol; Middle Aged; Personality Inventory | 1992 |